跳至主要内容
临床试验/NCT04890418
NCT04890418Unknown4 期

Risk Factors and Prevention of Severe Pain Upon Cessation of a Peripheral Nerve Block. A Prospective Randomized Study in Ambulatory Patients Undergoing Upper Limb Bone Surgery Under Single Shot Axillary Plexus Block

Cliniques universitaires Saint-Luc- Université Catholique de Louvain1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
100
试验地点
1
主要终点
incidence of severe postoperative rebound pain

研究概览

简要总结

Risk factors and Prevention of severe Pain upon cessation of a peripheral nerve block. A prospective randomized study in ambulatory patients undergoing upper limb bone surgery under single shot axillary plexus block.

详细描述

Pain in the course of upper limb bone surgery is a major source of discomfort for patients during postoperative time.

Severe post-operative pain is a risk factor for chronic pain. Use of a well-known molecule, regularly used in anesthesiology. Prospective double-blind study on 120 patients. Pain rebound upon awakening of the axillary plexus during upper limb bone surgery is a frequent phenomenon in post-operative follow-up of patients.

The anti-hyperalgesic properties of ketamine could be a benefit against this effect.

No studies have combined intravenous ketamine with localoregional anesthesia to reduce pain upon its release.

This may improve patients' post-operative comfort. The patients will be randomized in 2 groups and allocated to receive (slow intravenous injection) either 0.3 mg/kg intravenous ketamine diluted into 10mL saline or 10 mL 0.9% saline after the realization of PNB, before tourniquet set up and beginning of surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

The local pharmacy department is in charge of unmasking the drug.

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • any ambulatory upper limb bone surgery carried out under axillary PNB

排除标准

  • Refusal to participate
  • Contraindication to the use of ketamine
  • Contraindication to regular use of postoperative analgesics like non-steroidal anti-inflammatory drugs and paracetamol
  • Pregnant woman
  • Diabetic patient
  • Vascular patient
  • Cognitive disorders
  • Inability to answer perioperative questionnaires (language problem)

研究组 & 干预措施

Study drug

Active Comparator

0.3 mg/kg intravenous ketamine diluted into 10mL saline after the realization of peripheral nerve block (PNB), before tourniquet set up and beginning of surgery

干预措施: Ketalar, 5 mg/mL Injectable Solution (Drug)

Placebo

Placebo Comparator

10 mL 0.9% saline after the realization of PNB, before tourniquet set up and beginning of surgery

干预措施: Placebo (Other)

结局指标

主要结局

incidence of severe postoperative rebound pain

时间窗: from surgery to 30 days post operation

Rebound pain after PNB is defined as a Numerical rating Scale of 7 or more.

次要结局

  • To measure the impact of ketamine on the level of "rebound pain" in patients with central sensitivity using the Numerical Rating Scale(from surgery to 30 days postoperatively)

研究者

发起方
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验